Inflammatory Cell Infiltrate in Prostatic Disease
Author Information
Author(s): S. McClinton, I.D. Miller, O. Eremin
Primary Institution: University of Aberdeen
Hypothesis
The study aims to characterize the immune response in benign and malignant prostatic disease.
Conclusion
The immune response in hyperplasia and adenocarcinoma of the prostate is similar, suggesting that the prostate may not be immunologically privileged.
Supporting Evidence
- T-lymphocytes were the main type of immune cell found in both benign and malignant prostate tissues.
- There was no significant difference in the immune response between hyperplasia and adenocarcinoma.
- The study suggests that the prostate may not be an immunologically privileged site.
Takeaway
Doctors looked at the immune cells in the prostate of sick men and found that the immune response was the same for both benign and cancerous conditions.
Methodology
The study used immunohistochemical techniques to analyze the inflammatory cell infiltrate in prostate tissue from patients with hyperplasia and adenocarcinoma.
Limitations
The study may not account for all variables affecting immune response in prostate disease.
Participant Demographics
The mean age of participants was 70 years for hyperplasia and 74 years for adenocarcinoma, with a range of 52-88 years and 60-86 years respectively.
Statistical Information
P-Value
P>0.5
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website